The metabolic syndrome in women: a growing problem for cardiac risk
1Heart Function Clinic, Western Piedmont Heart Centers, 1771 Tate Boulevard SE, Suite 201, Hickory, NC 28602, USA. smcpaul@earthlink.net
Insights
Metabolic syndrome, a cluster of risk factors including obesity and hypertension, significantly increases cardiovascular disease risk. Lifestyle changes like weight reduction and exercise are key to managing this condition, especially in women.
Area of Science:
- Cardiology
- Endocrinology
- Women's Health
Background:
- Cardiovascular disease (CVD) risk is linked to metabolic and physiological factors like abdominal obesity, dyslipidemia, hypertension, and hyperglycemia.
- Metabolic syndrome (MetS) is the common term for this cluster of risk factors.
- Individuals with MetS have a tripled risk of coronary heart disease (CHD).
Purpose of the Study:
- To review the definition, prevalence, pathogenesis, and treatment of MetS specifically in women.
- To explore the relationship between polycystic ovarian syndrome (PCOS) and MetS.
Main Methods:
- Literature review of existing studies on MetS and PCOS.
- Analysis of epidemiological data on MetS prevalence in women.
- Synthesis of current understanding of MetS pathogenesis and treatment strategies.
Main Results:
- MetS is a significant risk factor for CVD, particularly in women.
- PCOS is frequently associated with MetS, suggesting a shared pathophysiology.
- Weight reduction and increased physical activity are primary treatment modalities.
Conclusions:
- MetS poses a substantial threat to cardiovascular health in women.
- Understanding the link between PCOS and MetS is crucial for effective management and prevention strategies.
- Lifestyle interventions are paramount in mitigating MetS-related risks.
Abstract:
The risk of developing cardiovascular disease has recently been associated with a set of metabolic and physiological risk factors that include abdominal obesity, atherogenic dyslipidemia, hypertension, and elevated plasma glucose. The term most commonly used to describe this conglomeration of risk factors is the metabolic syndrome. Coronary heart disease risk is tripled in those individuals with this syndrome. Primary treatment focuses on weight reduction and physical activity to reduce risk factors and prevent the progression to cardiovascular disease. This article will review the definition, prevalence, pathogenesis, and treatment of the metabolic syndrome in women and will discuss the role of polycystic ovarian syndrome in relation to the metabolic syndrome.
Related Concept Videos
Coronary Artery Disease I: Introduction
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Type II Diabetes I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
